Charles Tamburello was appointed as Director at Cannabis Bioscience International Holdings, Inc..
“filled the vacancy thus created with Charles Tamburello, who will serve from December 1, 2024, until the next annual meeting of shareholders.”
Cannabis Bioscience International Holdings, Inc. — fact timeline
Source-grounded facts extracted from Cannabis Bioscience International Holdings, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
John Jones was appointed as Director and Treasurer at Cannabis Bioscience International Holdings, Inc..
“On August 20, 2024, pursuant to the Jones Agreement, Jones was appointed as a director by the board of directors, acting pursuant to the Registrant’s by-laws, to fill the vacancy in the board of directors created by the death of Henry Levinski on December 29, 2023, and as treasurer of the Registrant.”
Cannabis Bioscience International Holdings, Inc. entered into Securities Purchase Agreement with 1800 Diagonal Lending LLC valued at $66,000 (effective 2024-03-14).
“On March 14, 2024, the Registrant and 1800 Diagonal Lending LLC, a Virginia limited liability company, entered into a Securities Purchase Agreement (the “SPA”), under which the Registrant agreement to make, and the Lender agreed to purchase a promissory note, dated as of March 14, 2024, in the principal amount of $66,000 (the “Note”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.